Search

everythinglearnresearchcommunity

for

Search:↓

Biotin supplements increased biotin levels but did not significantly prevent hair loss in rats on valproic acid.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Valproic acid can cause hair loss, but information on hair color change is not detailed.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Treating epilepsy is complex, requiring careful drug choice and patient adherence to manage seizures and side effects.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Dopaminergic therapy in Parkinson's disease patients is linked to increased hair loss.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Acne keloidalis nuchae is a chronic skin condition more common in African men, causing itchy or painful bumps and can lead to permanent hair loss if not treated early.

The dietary supplement helped increase hair growth in women with hair loss.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.